Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
7314 | 1303 | 38.8 | 66% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
2056 | 4850 | MAMMARY GLAND//MOUSE MAMMARY TUMOR VIRUS//JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | MOUSE MAMMARY TUMOR VIRUS | Author keyword | 9 | 27% | 2% | 28 |
2 | VIRAL SUPERANTIGEN | Author keyword | 6 | 71% | 0% | 5 |
3 | MAMMARY TUMOR VIRUS | Author keyword | 5 | 43% | 1% | 9 |
4 | MMTV | Author keyword | 4 | 17% | 2% | 20 |
5 | MLS 1A | Author keyword | 2 | 50% | 0% | 3 |
6 | ANTI MLSA ANTIBODY | Author keyword | 1 | 100% | 0% | 2 |
7 | EXTRATHYMIC TOLERANCE | Author keyword | 1 | 50% | 0% | 2 |
8 | IMMUNOLIMM4A | Address | 1 | 50% | 0% | 2 |
9 | PEDIAT BASIC SCI | Address | 1 | 33% | 0% | 3 |
10 | DAVID F HICKOK MEM CANC | Address | 1 | 40% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MLSA ENCODED ANTIGENS | 32 | 57% | 3% | 38 |
2 | CLONAL DELETION | 26 | 15% | 12% | 160 |
3 | MAMMARY TUMOR VIRUS | 16 | 11% | 11% | 138 |
4 | VIRAL SUPERANTIGEN | 15 | 82% | 1% | 9 |
5 | I E | 14 | 34% | 3% | 34 |
6 | MTV 7 | 14 | 100% | 1% | 7 |
7 | IMPARTS REACTIVITY | 9 | 47% | 1% | 15 |
8 | MLSA | 9 | 83% | 0% | 5 |
9 | MLSA DETERMINANTS | 9 | 83% | 0% | 5 |
10 | PROVIRAL ACTIVATION | 9 | 44% | 1% | 15 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
SUPERANTIGENS OF MOUSE MAMMARY-TUMOR VIRUS | 1995 | 126 | 138 | 81% |
MMTV-induced mammary tumorigenesis: gene discovery, progression to malignancy and cellular pathways | 2000 | 98 | 84 | 35% |
SUPERANTIGENS AND RETROVIRAL INFECTION - INSIGHTS FROM MOUSE MAMMARY-TUMOR VIRUS | 1994 | 76 | 44 | 73% |
PERIPHERAL T-CELL TOLERANCE | 1992 | 200 | 63 | 49% |
Mouse Mammary Tumor Virus Molecular Biology and Oncogenesis | 2010 | 19 | 71 | 41% |
Mouse mammary tumor virus: Immunological interplays between virus and host | 1997 | 41 | 446 | 55% |
Evidence for a thymus-dependent form of tolerance that is not based on elimination or anergy of reactive T cells | 1996 | 76 | 46 | 43% |
INFLUENCE OF VIRAL SUPERANTIGENS ON V-BETA-SPECIFIC AND V-ALPHA-SPECIFIC POSITIVE AND NEGATIVE SELECTION | 1993 | 87 | 94 | 70% |
MLS - A RETROVIRUS EXPLOITS THE IMMUNE-SYSTEM | 1991 | 217 | 55 | 75% |
EXOGENOUS AND ENDOGENOUS MOUSE MAMMARY-TUMOR VIRUS SUPERANTIGENS | 1993 | 63 | 75 | 80% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | IMMUNOLIMM4A | 1 | 50% | 0.2% | 2 |
2 | PEDIAT BASIC SCI | 1 | 33% | 0.2% | 3 |
3 | DAVID F HICKOK MEM CANC | 1 | 40% | 0.2% | 2 |
4 | FOR UNGS WERPUNKT ANGEW TUMORVIROL F0400 | 1 | 40% | 0.2% | 2 |
5 | LEUCEMIA EXPT | 1 | 33% | 0.2% | 2 |
6 | LEGMA | 1 | 50% | 0.1% | 1 |
7 | MED BASIC IMMUNOL | 1 | 50% | 0.1% | 1 |
8 | ILEX CONICET | 1 | 25% | 0.2% | 2 |
9 | ILEX | 1 | 22% | 0.2% | 2 |
10 | BIOCHIM NEUROENDOCRINIENNE | 0 | 33% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000228053 | HMTV//MOUSE MAMMARY TUMOR VIRUS//HUMAN MAMMARY TUMOR VIRUS |
2 | 0.0000172441 | SUPERANTIGEN//STAPHYLOCOCCAL ENTEROTOXIN B//SUPERANTIGENS |
3 | 0.0000129900 | ANTI B CELL ANTIBODY//FOLLICULAR CENTER CELL//IN SITU IMMUNOPHENOTYPING |
4 | 0.0000120599 | HLTH SCI PATHOL HMR 301 2011 ZONAL AVE//INTRACELLULAR ANTIGEN//CENTENARY CANC CELL BIOL |
5 | 0.0000115758 | T CELL DEVELOPMENT//PRE T CELL RECEPTOR//THYMIC SELECTION |
6 | 0.0000115186 | NUCLEAR FACTOR 1//NUCLEAR FACTOR I//DEV GENOM GRP |
7 | 0.0000087207 | GENET CELL BIOL SECTCHUO KU//GENET CELL BIOL SECT//INTEGROME NETWORK |
8 | 0.0000074016 | SECRETION INHIBITION//RNF13//PROTEASE ASSOCIATED DOMAIN |
9 | 0.0000072286 | THYMUS//THYMIC NURSE CELLS//THYMIC MICROENVIRONMENT |
10 | 0.0000068289 | SPECTRATYPING//CDR3//T CELL REPERTOIRE |